Joseph Cabaret, MD
Interventional Pain Medicine · Camarillo, CANPI 1689600041
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,539 of the $7,276 with a category attached, or 89.9%. 33 manufacturers reported payments, led by Medtronic at 46.9% of the total. Reporting peaked in 2023 at $1,801 and has fallen 76.9% since, to $416 in 2025.
Across 188 payments — averaging $38.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Relievant Medsystems, Inc.$748
- AbbVie$457
- Neuronetics, Inc.$318
- Boston Scientific$240
- Nevro Corp.$226
- plus $2K from 27 others
What the payments were for
- Consulting fees$3104%
- Travel & lodging$4276%
- Food & beverage$6,53990%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 75 | $3,410 |
| Relievant Medsystems, Inc. | 10 | $748 |
| AbbVie(2 entities) | 19 | $457 |
| Neuronetics, Inc. | 7 | $318 |
| Boston Scientific | 6 | $240 |
| Nevro Corp. | 2 | $226 |
| Collegium Pharmaceutical, Inc. | 11 | $218 |
| Abbott | 2 | $217 |
| Amgen | 7 | $141 |
| Stimwave Technologies Incorporated | 2 | $119 |
| Indivior Inc. | 1 | $98 |
| Curonix LLC | 1 | $98 |
| Almatica Pharma LLC | 5 | $96 |
| Vertex | 3 | $94 |
| Biohaven Pharmaceuticals, Inc. | 5 | $90 |
| Painteq LLC | 4 | $80 |
| SPR Therapeutics, Inc | 1 | $73 |
| Arbor Pharmaceuticals, Inc. | 3 | $68 |
| Johnson & Johnson | 3 | $64 |
| Novartis | 3 | $55 |
| Tersera Therapeutics LLC | 2 | $46 |
| Lundbeck LLC | 2 | $45 |
| Biotronik NRO, Inc. | 1 | $37 |
| Pfizer | 2 | $35 |
| Scilex Pharmaceuticals Inc. | 2 | $34 |
| Biodelivery Sciences International, Inc. | 2 | $30 |
| Flowonix Medical Incorporated | 1 | $29 |
| Alkermes, Inc. | 1 | $23 |
| MML US, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Saluda Medical Americas, Inc. | 1 | $17 |
| Tonix Medicines, Inc. | 1 | $16 |
| Vertiflex, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,146
- Accurian$396
- INTELLIS ADAPTIVESTIM$273
- Omnia$176
- Proclaim Family of SCS IPGs$155
- NEUROSTAR TMS THERAPY SYSTEM$116
How this compares
$7,276 in reported general payments places this provider in the 70th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 19 | $4,813 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 27 | $2,755 |
| Gabapentin | 49 | $529 |
| Duloxetine Hcl | 59 | $480 |
| Pregabalin | 14 | $329 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $223 |
| Meloxicam | 12 | $66 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Camarillo
- Patrick BuchananCamarillo$219K
- Michael Verdolinla Mesa$507K
- Tim LeierRancho Mirage$449K
- Jonathan GrossmanVisalia$404K
- Kasra MaasumiRancho Santa Margarita$388K
- Andrew GermanovichRancho Mirage$333K
- David LeeYorba Linda$257K
- Standiford HelmOrange$254K
- Chau VuSanta Rosa$141K
- Phillip LimBuena Park$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.